Credent Connect N Care Limited IPO — Subscription & GMP

Business Model of Credent Connect N Care Limited

Credent Connect N Care Limited operates as an integrated B2B healthcare operations partner, specializing in specialized supply chain and logistics solutions for the medical and diagnostic sectors. Originally established in 2015 as a cold-chain logistics startup, it has evolved to provide end-to-end operational support to diagnostic laboratories, IVD companies, hospitals, and pharmaceutical firms.

• Core Offerings: The company’s services focus heavily on pre-analytical and supply-chain operations. This includes the temperature-controlled and Turnaround Time (TAT) sensitive transportation of diagnostic samples (such as blood samples) and reagents. Additionally, it provides extensive workforce solutions by deploying trained phlebotomists for home sample collection and stationing paramedical staff and laboratory technicians directly at client hospitals and clinics.
• Technology Integration: To support its logistics capabilities, Credent Connect utilizes advanced technologies, including IoT-based tracking devices and real-time temperature monitoring, ensuring the integrity of critical medical specimens during transit.
• Revenue Generation: The company earns its revenue through B2B service-level contracts with healthcare institutions, acting as a back-end partner that manages logistical friction and streamlines diagnostic operations. However, its business model relies heavily on its top 10 customers and the broader diagnostic industry, exposing it to risks related to contract renewals and the continuous need to retain a highly skilled, geographically dispersed workforce.